Ondine Biomedical, Inc. (GB:OBI) has released an update.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Ondine Biomedical Inc. successfully held its Annual General Meeting on June 28, 2024, with all proposed resolutions passed unanimously, signaling strong support from the shareholders. As a leader in light-activated antimicrobial therapies, the company continues to advance its photodisinfection technology with multiple products in development and a nasal photodisinfection system that has received international approvals and is undergoing clinical trials in the US.
For further insights into GB:OBI stock, check out TipRanks’ Stock Analysis page.
